Placebo
Placebo is an intervention with 42,055 clinical trials. Currently 4,811 active trials ongoing. Historical success rate of 87.4%.
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
8354 source entries across 8152 studies. This list may not include all unresolved or historical entries.
- PlaceboRegistry intervention
Linked study entry; product equivalence not established
View study and source - PlaceboRegistry intervention
Linked study entry; product equivalence not established
View study and source - PlaceboRegistry intervention
Linked study entry; product equivalence not established
View study and source - PlaceboRegistry intervention
Linked study entry; product equivalence not established
View study and source - PlaceboRegistry intervention
Linked study entry; product equivalence not established
View study and source - placeboRegistry intervention
Linked study entry; product equivalence not established
View study and source - PlaceboRegistry intervention
Linked study entry; product equivalence not established
View study and source - placeboRegistry intervention
Linked study entry; product equivalence not established
View study and source - PlaceboRegistry intervention
Linked study entry; product equivalence not established
View study and source - PlaceboRegistry intervention
Linked study entry; product equivalence not established
View study and source - PlaceboRegistry intervention
Linked study entry; product equivalence not established
View study and source - PlaceboRegistry intervention
Linked study entry; product equivalence not established
View study and source - PlaceboRegistry intervention
Linked study entry; product equivalence not established
View study and source - PlaceboRegistry intervention
Linked study entry; product equivalence not established
View study and source - PlaceboRegistry intervention
Linked study entry; product equivalence not established
View study and source - PlaceboRegistry intervention
Linked study entry; product equivalence not established
View study and source - placeboRegistry intervention
Linked study entry; product equivalence not established
View study and source - PlaceboRegistry intervention
Linked study entry; product equivalence not established
View study and source - PlaceboRegistry intervention
Linked study entry; product equivalence not established
View study and source - PlaceboRegistry intervention
Linked study entry; product equivalence not established
View study and source
Success Metrics
Based on 26,997 completed trials
Phase Distribution
Phase Distribution
7239
Early Stage
14567
Mid Stage
13171
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.6%
26997 of 32277 finished
16.4%
5280 ended early
4700
trials recruiting
42,055
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Spironolactone for Pulmonary Arterial Hypertension
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia
A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia
Clinical Trials (42,055)
Spironolactone for Pulmonary Arterial Hypertension
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia
A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia
Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy
Efficacy of Spinal Manipulation Therapy or Mindfulness-based Reduction Therapy on Patients With Chronic Low Back Pain
Effect of Propionic Acid Supplementation on Endothelial Function
Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction
Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis
Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission
Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia
A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus
A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus
Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity
Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery
Drug Details
- Intervention Type
- Varies by study
- Total Trials
- 42,055